What would be the most suitable approach in target validation if you have a disease model and a diverse library of compounds?如果你拥有疾病模型和多样化的化合物库，靶点验证中最合适的方法是什么？Single choice

a. A forward genetic approach, using random gene knockdown, knockout, or overexpression to identify the role of specific genes in the disease.一种前瞻性遗传学方法，利用随机基因敲低、敲除或过度表达来识别特定基因在疾病中的作用。

b. A biomarker-driven approach, identifying disease-associated biomarkers and correlating them with potential targets.一种以生物标志物为驱动的方法，识别与疾病相关的生物标志物并将其与潜在靶点关联起来。

c. A computational approach, using bioinformatics and in silico modelling to predict potential drug-target interactions.一种利用生物信息学和计算机模拟预测潜在药物与靶点相互作用的计算方法。

d. A forward pharmacological approach, screening a diverse compound library in a disease model to identify active compounds and subsequently determine their molecular targets.一种前瞻性药理学方法 ，在疾病模型中筛选多样化的化合物库，以识别活性化合物并最终确定其分子靶点。